Viehbacher, "Biogen") announced today that the humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody "LEQEMBI®" has been launched in South Korea. LEQEMBI received the Ministry of ...

The biotechnology company, which sees itself as "pretty conservative," recently put out an ambitious long-term revenue ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

SOS Ltd., a multifaceted company that engages in the blockchain, cryptocurrency operations and commodity trading, today announced the Board of Directors approved its plan to invest $50 million to ...

While a long-term play, the new agreement is a further sign of Biogen's efforts to rebuild its ... president and CEO of Interius Biotherapeutics. The launch environment for pharmaceutical industry ...

Biogen has revealed ... are an invaluable asset. In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.

Sumitomo Corporation and Rikkeisoft Corporation today announced a strategic partnership aimed at mutual business growth and ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

Cassava Sciences’ SAVA stock shed more than 80% of market value on Monday after the company reported that its lead pipeline ...

PTC Therapeutics faces significant risks with its key revenue sources, Translarna and Emflaza. Find out why I am sticking ...

O'Neil will inherit a tour that has become increasingly worldwide but needs a long-term TV carrier in the United States.

TSMC founder Morris Chang and Nvidia CEO Jensen Huang have long-admired each other publicly — but Huang decided to keep his ...